Sage Journals: Discover world-class research

Open access

Research article

First published 2020-11

Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies

Bart Van Wijmeersch, Barry A Singer, Aaron Boster [...]

Multiple Sclerosis Journal

Free access

Research article

First published 2016-7

Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey

Rocco Haase, Jennifer S. Kullmann, Tjalf Ziemssen

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 1997-01

Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials

L Truyen, F Barkhof, M Tas [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 1997-04

Treatment effects of monthly intravenous immunoglobulin on patients with relapsing - remitting Multiple Sclerosis: Further analyses of the Austrian immunoglobulin in MS Study

Franz Fazekas, Florian Deisenhammer, Siegrid Strasser-Fuchs [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2023-12

Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study

Barry A Singer, Douglas L Arnold, Jelena Drulovic [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2020-7

Impact of alemtuzumab on health-related quality of life over 6 years in CARE-MS II trial extension patients with relapsing-remitting multiple sclerosis

Rafael Arroyo, Denise P Bury, Jennifer D Guo [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2021

Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis

Qi Wu, Qin Wang, Jennifer Yang [...]

Journal of Central Nervous System Disease

Open access

Research article

First published 2020-11

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

Robert T Naismith, Jerry S Wolinsky, Annette Wundes [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025

Switch from fingolimod to ozanimod for safety or intolerance reasons

Elisabetta Signoriello, Giuseppe Romano, Matteo Foschi [...]

Therapeutic Advances in Neurological Disorders

Free access

Research article

First published 2008-1

Perfusion Magnetic Resonance Imaging Correlates of Neuropsychological Impairment in Multiple Sclerosis

Matilde Inglese, Sumita Adhya, Glyn Johnson [...]

Journal of Cerebral Blood Flow & Metabolism

Search results